Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer have?
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer has 392 citations in the OpenAlex counts ScholarIQ stores.
When was Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer published?
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer has 2016 year in the ScholarIQ index.
What is the open-access status of Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer?
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer?
The DOI for Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer is on the source record.
What is the PMID of Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer?
The PMID for Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer is on the source record.
What is the OpenAlex record for Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer?
The OpenAlex for Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer is on the source record.